Pathways to Cardiovascular Therapeutics

心血管治疗途径

• 批准号: 8986055
• 负责人: Joshua M Hare
• 金额: $ 3万
• 依托单位: UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-07-01 至 2016-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8986055
• 关键词: American Heart Association; Anniversary; Area; Award; Back; Biology; Budgets; Cardiac; Cardiac development; Cardiology; Cardiovascular system; Cell Therapy; Cells; Collaborations; Communities; Disabled Persons; Disease; Disease Progression; Ensure; Epigenetic Process; Equilibrium; Event; Family; Fostering; Functional disorder; Funding; Future; Goals; Grant; Heart Diseases; Heart failure; Homeostasis; Individual; Institutes; Investments; Israel; Learning; Left; Life; Location; Louisiana; Medical Research; Medical center; MicroRNAs; Minority; Molecular; National Heart, Lung, and Blood Institute; Oral; Pathway interactions; Recruitment Activity; Request for Proposals; Research; Research Personnel; Schedule; Science; Scientist; Secure; Signal Pathway; Site; Stem Cell Research; Therapeutic; Time; Tissue Engineering; Travel; Uncertainty; Underrepresented Minority; Universities; Utah; Work; abstracting; career; combat; cost; design; experience; follow-up; gene therapy; heart metabolism; induced pluripotent stem cell; lectures; medical specialties; meetings; methionylmethionine; next generation; novel; outreach; posters; programs; public health relevance; success; symposium; therapeutic target; trend

 DESCRIPTION (provided by applicant): This is a new application for the Annual Summer 2015 Symposium of the Basic Cardiovascular Sciences (BCVS) of the American Heart Association (AHA). This conference has had continuous support from the NHLBI for the last 10 years and this will be the 11th Anniversary meeting. Support from the NHLBI has helped foster a meeting that has become the "go to" conference dealing with molecular cardiovascular biology and disease. It represents its sponsor, the BCVS of the AHA, which is the world's leading organization of cardiovascular scientists. This conference started originally two decades ago as the Council held a Molecular Cardiology conference in 1991 and then had several meetings initially hailed as the Snowbird Conference as it was held during the summer at Snowbird, Utah. The meeting became an annual event in 2002 and since 2004 this conference has been recognized as a permanent, recurring scientific meeting of the AHA and which is when R13 funding also commenced. The conference in recent years has added translational topics as well as the "bread and butter" of this meeting, which is basic molecular cardiovascular research. The conference has always attracted the leading researchers in fields such as microRNA, cardiac gene and cell therapy, cardiac development and most recently, tissue engineering and iPS cells. The attendance of this conference has climbed every year and in 2014 we had an all-time high attendance of over 600. As in past years, the conference will be held in July and this year will return to New Orleans (the site of the 2011 and 2012 meetings) after two years in Las Vegas. The meeting will be held at the Hilton New Orleans Riverside, New Orleans, LA. The planned agenda represents an ambitious, fast-paced meeting with 14 sessions over 4 days (July 13-16, 2015) including the Keynote lecture by Dr. Eric Olson. Young cardiovascular scientists will be highlighted as well through invited talks in each session and Posters will be presented over the course of 3 days of the conference. Organizers of this meeting are Drs. Asa Gustafsson (UCSD), Anthony Rosenzweig (Beth Israel Deaconess Medical Center) and David J. Lefer (Louisiana State University). The proposal request constitutes approximately 7% of the total meeting budget and as we have done over the last several years, support from this application will be used toward Cardiovascular Outreach Awards (minority travel awards) and Young Investigator Travel Awards.

 描述（由申请人提供）：这是美国心脏协会 (AHA) 2015 年夏季基础心血管科学 (BCVS) 年度研讨会的新申请。该会议在过去 10 年中得到了 NHLBI 的持续支持。这将是 11 周年纪念会议，NHLBI 的支持帮助促成了一次会议，该会议已成为处理分子心血管生物学和疾病的“必去”会议，它代表了其赞助商 BCVS。 AHA 是世界领先的心血管科学家组织，该会议最初始于 20 年前，当时理事会于 1991 年举办了一次分子心脏病学会议，随后又召开了几次会议，最初被称为“雪鸟会议”，于夏季在犹他州斯诺伯德。该会议于 2002 年成为年度活动，自 2004 年以来，该会议被认为是 AHA 的永久性、定期举行的科学会议，R13 资助也于最近开始。多年来增加了翻译主题以及本次会议的“面包和黄油”，这是基础分子心血管研究，该会议一直吸引着microRNA、心脏基因和细胞治疗、心脏发育等领域的领先研究人员。 、组织工程和 iPS 细胞的参会人数每年都在增加，2014 年我们的参会人数达到了历史新高，超过了 600 人。与往年一样，会议将于 7 月举行，今年将重返新的一年。奥尔良（该网站两年后的 2011 年和 2012 年会议将在洛杉矶新奥尔良新奥尔良河滨希尔顿酒店举行。计划的议程是一次雄心勃勃、快节奏的会议，为期 4 天（7 月 13 日至 7 月 13 日）。 2015 年 16 月 16 日），包括埃里克·奥尔森 (Eric Olson) 博士的主题演讲，每场会议还将通过受邀演讲进行重点介绍，并在为期 3 天的会议期间展示海报。本次会议的组织者是 Asa Gustafsson 博士（加州大学圣地亚哥分校）、Anthony Rosenzweig（贝斯以色列女执事医疗中心）和 David J. Lefer（路易斯安那州立大学），该提案请求约占会议总预算的 7%。在过去的几年中，该应用程序的支持将用于心血管外展奖（少数族裔旅行奖）和青年研究者旅行奖。